Published in Clin Exp Immunol on February 01, 2001
HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Rev (2011) 3.28
Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev (2001) 2.87
Effect of treating co-infections on HIV-1 viral load: a systematic review. Lancet Infect Dis (2010) 2.60
HIV-1/mycobacterium tuberculosis coinfection immunology: how does HIV-1 exacerbate tuberculosis? Infect Immun (2011) 2.03
Maternal tuberculosis: a risk factor for mother-to-child transmission of human immunodeficiency virus. J Infect Dis (2011) 1.50
Immunopathogenesis of asymptomatic chronic HIV Infection: the calm before the storm. Curr Opin HIV AIDS (2009) 1.39
The impact of co-infections on fish: a review. Vet Res (2016) 1.39
The role of coinfections in HIV epidemic trajectory and positive prevention: a systematic review and meta-analysis. AIDS (2011) 1.38
Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol (2002) 1.27
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Inhibition of human immunodeficiency virus-1 (HIV-1) by beta-chemokine analogues in mononuclear cells from HIV-1-infected patients with active tuberculosis. Clin Exp Immunol (2005) 1.05
Inclusion and human rights in health policies: comparative and benchmarking analysis of 51 policies from Malawi, Sudan, South Africa and Namibia. PLoS One (2012) 1.03
Clinical and immune impact of Mycobacterium bovis BCG vaccination scarring. Infect Immun (2002) 1.01
Effects of antiretroviral therapy on immune function of HIV-infected adults with pulmonary tuberculosis and CD4+ >350 cells/mm3. J Infect Dis (2011) 0.95
HIV-1 replication is differentially regulated by distinct clinical strains of Mycobacterium tuberculosis. PLoS One (2009) 0.94
X-ray crystal structure of Mycobacterium tuberculosis beta-ketoacyl acyl carrier protein synthase II (mtKasB). J Mol Biol (2006) 0.91
Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun (2004) 0.90
The role of co-infections in mother-to-child transmission of HIV. Curr HIV Res (2013) 0.90
Impact of HIV co-infection on plasma level of cytokines and chemokines of pulmonary tuberculosis patients. BMC Infect Dis (2014) 0.88
Lymphocyte proliferation to mycobacterial antigens is detectable across a spectrum of HIV-associated tuberculosis. BMC Infect Dis (2009) 0.87
Mycobacterium tuberculosis complex enhances susceptibility of CD4 T cells to HIV through a TLR2-mediated pathway. PLoS One (2012) 0.86
HIV-1 infection of macrophages dysregulates innate immune responses to Mycobacterium tuberculosis by inhibition of interleukin-10. J Infect Dis (2013) 0.84
Impairment of beta chemokine and cytokine production in patients with HIV related Pneumocystis jerovici pneumonia. Thorax (2004) 0.84
Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology (2008) 0.84
Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. J Acquir Immune Defic Syndr (2008) 0.83
Activation of P-TEFb at sites of dual HIV/TB infection, and inhibition of MTB-induced HIV transcriptional activation by the inhibitor of CDK9, Indirubin-3'-monoxime. AIDS Res Hum Retroviruses (2011) 0.83
Induction of HIV type 1 expression correlates with T cell responsiveness to mycobacteria in patients coinfected with HIV type 1 and Mycobacterium tuberculosis. AIDS Res Hum Retroviruses (2009) 0.82
Copy number variation of Fc gamma receptor genes in HIV-infected and HIV-tuberculosis co-infected individuals in sub-Saharan Africa. PLoS One (2013) 0.82
Interferon-gamma and tumour necrosis factor-alpha production by CD4+ T and CD8+ T lymphocytes in AIDS patients with tuberculosis. Clin Exp Immunol (2005) 0.81
The effect of opportunistic illness on HIV RNA viral load and CD4+ T cell count among HIV-positive adults taking antiretroviral therapy. J Int AIDS Soc (2013) 0.81
Malaria parasitemia and CD4 T cell count, viral load, and adverse HIV outcomes among HIV-infected pregnant women in Tanzania. Am J Trop Med Hyg (2010) 0.80
Prevalence and predictors of HIV among Chinese tuberculosis patients by provider-initiated HIV testing and counselling (PITC): a multisite study in South Central of China. PLoS One (2014) 0.79
Human immunodeficiency virus and leprosy coinfection: challenges in resource-limited setups. Case Rep Med (2012) 0.77
Demographic and clinical correlates of HIV-1 RNA levels in antiretroviral therapy-naive adults attending a tertiary hospital in Jos, Nigeria. J Virus Erad (2017) 0.75
A structured approach to recording AIDS-defining illnesses in Kenya: A SNOMED CT based solution. J Biomed Inform (2015) 0.75
Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia. BMC Infect Dis (2015) 0.75
Cigarette smoking is associated with high HIV viral load among adults presenting for antiretroviral therapy in Vietnam. PLoS One (2017) 0.75
Cohort profile of a study on outcomes related to tuberculosis and antiretroviral drug concentrations in Uganda: design, methods and patient characteristics of the SOUTH study. BMJ Open (2017) 0.75
Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA (1999) 27.82
Tuberculosis in patients with human immunodeficiency virus infection. N Engl J Med (1991) 8.98
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Macrophages as a source of HIV during opportunistic infections. Science (1997) 3.92
Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Respir Crit Care Med (1995) 3.29
Effect of Mycobacterium tuberculosis on HIV replication. Role of immune activation. J Immunol (1996) 2.86
Prognostic significance of plasma markers of immune activation, HIV viral load and CD4 T-cell measurements. AIDS (1998) 2.33
Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung. Am J Respir Crit Care Med (1997) 1.83
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76
Impact of opportunistic disease on survival in patients with HIV infection. AIDS (1998) 1.71
Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virus. J Acquir Immune Defic Syndr (1994) 1.35
Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J Exp Med (1993) 1.19
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. J Infect Dis (1996) 1.12
Sustained plasma TNF-alpha and HIV-1 load despite resolution of other parameters of immune activation during treatment of tuberculosis in Africans. AIDS (1999) 1.12
Activation of latent HIV-1 by Mycobacterium tuberculosis and its purified protein derivative in alveolar macrophages from HIV-infected individuals in vitro. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 1.06
Tuberculosis generates a microenvironment enhancing the productive infection of local lymphocytes by HIV. J Immunol (1997) 1.05
Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes. Clin Exp Immunol (1999) 0.95
The effect of latent Mycobacterium tuberculosis infection on human immunodeficiency virus (HIV) disease progression and HIV RNA load among injecting drug users. J Infect Dis (1996) 0.86
WHO gives southeast Asia a health warning. Lancet (1999) 0.82
Short-term risk for AIDS-indicator diseases predicted by plasma HIV-1 RNA and CD4+ lymphocytes. Scand J Infect Dis (1999) 0.82
A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration. N Engl J Med (1997) 8.43
Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial. Lancet (2009) 7.96
Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol (2003) 3.09
Suppressor adherent cells in human tuberculosis. J Immunol (1978) 2.68
Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages. J Immunol (1994) 2.52
Induction of interleukin 1 and tumor necrosis factor by mycobacterial proteins: the monocyte western blot. Proc Natl Acad Sci U S A (1990) 2.46
Mycobacterium avium complex infection and AIDS: advances in theory and practice. Clin Infect Dis (1993) 2.39
Human immune response to Mycobacterium tuberculosis antigens. Infect Immun (1991) 2.39
Impact of pulmonary tuberculosis on survival of HIV-infected adults: a prospective epidemiologic study in Uganda. AIDS (2000) 2.32
Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes. J Immunol (1991) 2.29
Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions. J Immunol (1995) 2.21
Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens. Infect Immun (1988) 2.21
Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci U S A (1996) 2.15
Influence of tuberculosis on human immunodeficiency virus (HIV-1): enhanced cytokine expression and elevated beta 2-microglobulin in HIV-1-associated tuberculosis. J Infect Dis (1993) 2.14
Ambient temperature and mortality from unintentional cocaine overdose. JAMA (1998) 2.09
Infective endocarditis caused by slow-growing, fastidious, Gram-negative bacteria. Medicine (Baltimore) (1979) 2.09
Relationship of immunodiagnostic assays for tuberculosis and numbers of circulating CD4+ T-cells in HIV infection. Eur Respir J (2009) 2.07
Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis (1999) 2.06
Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens. J Immunol (1986) 2.05
Unexpected death in young epileptics. Neurology (1971) 2.01
Violent death in a metropolitan county. Changing patterns in homicide (1958-74). N Engl J Med (1977) 1.99
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol (1995) 1.98
Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J Exp Med (1999) 1.97
Drug tolerance in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1999) 1.94
Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med (1986) 1.88
Immunosuppression by mycobacterial arabinomannan. Clin Exp Immunol (1979) 1.87
A role for CD4+CD25+ T cells in regulation of the immune response during human tuberculosis. Clin Exp Immunol (2006) 1.86
A pilot study of antituberculosis combinations comparing rifabutin with rifampicin in the treatment of HIV-1 associated tuberculosis. A single-blind randomized evaluation in Ugandan patients with HIV-1 infection and pulmonary tuberculosis. Tuber Lung Dis (1995) 1.85
Increase in suicide by asphyxiation in New York City after the publication of Final Exit. N Engl J Med (1993) 1.85
The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children. Int J Tuberc Lung Dis (1999) 1.76
Enhancement of intracellular growth of Mycobacterium tuberculosis in human monocytes by transforming growth factor-beta 1. J Infect Dis (1994) 1.76
Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection. Clin Exp Immunol (1996) 1.76
A prospective study of community-acquired bloodstream infections among febrile adults admitted to Mulago Hospital in Kampala, Uganda. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.74
Duration of efficacy of treatment of latent tuberculosis infection in HIV-infected adults. AIDS (2001) 1.73
Mycobacterium africanum subtype II is associated with two distinct genotypes and is a major cause of human tuberculosis in Kampala, Uganda. J Clin Microbiol (2002) 1.72
Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy. Am J Respir Crit Care Med (1999) 1.67
A whole blood bactericidal assay for tuberculosis. J Infect Dis (2001) 1.65
Lower risk of suicide during pregnancy. Am J Psychiatry (1997) 1.63
Selective expansion of human gamma delta T cells by monocytes infected with live Mycobacterium tuberculosis. J Clin Invest (1991) 1.60
Intestinal helminth co-infection has a negative impact on both anti-Mycobacterium tuberculosis immunity and clinical response to tuberculosis therapy. Clin Exp Immunol (2007) 1.58
Cytochrome P450 2B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda. HIV Med (2007) 1.58
Asphyxial deaths and petechiae: a review. J Forensic Sci (2000) 1.58
Endomyocardial fibrosis: why is there striking ascites with little or no peripheral oedema? Lancet (1996) 1.53
In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci U S A (1997) 1.53
Induction of transforming growth factor beta 1 by purified protein derivative of Mycobacterium tuberculosis. Infect Immun (1995) 1.52
Pathogenicity of Mycobacterium avium for human monocytes: absence of macrophage-activating factor activity of gamma interferon. Infect Immun (1989) 1.52
Quantitative sputum bacillary load during rifampin-containing short course chemotherapy in human immunodeficiency virus-infected and non-infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis (2000) 1.51
The assessment of historical physical activity and its relation to adult bone parameters. Am J Epidemiol (1988) 1.51
Thromboxane A2 mediates augmented polymorphonuclear leukocyte adhesiveness. J Clin Invest (1980) 1.48
Human stress cardiomyopathy. Myocardial lesions in victims of homicidal assaults without internal injuries. Hum Pathol (1980) 1.47
Correlates of protective immunity to Mycobacterium tuberculosis in humans. Clin Infect Dis (2000) 1.46
Cytokines and tuberculosis. J Leukoc Biol (1994) 1.45
Suppression of antigen and mitogen induced human T lymphocyte DNA synthesis by bacterial lipopolysaccharide: mediation by monocyte activation and production of prostaglandins. J Immunol (1979) 1.45
Phytohemagglutinin-induced proliferation of guinea pig thymus-derived lymphocytes. I. Accessory cell dependence. J Immunol (1976) 1.45
Sexual behaviour among persons living with HIV/AIDS in Kampala, Uganda. East Afr Med J (2010) 1.44
Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis. J Infect Dis (1999) 1.44
Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis. J Infect Dis (2001) 1.43
Use of prescription psychotropic drugs among suicide victims in New York City. Am J Psychiatry (1995) 1.42
Risk factors for HIV infection in homosexual men: the Cleveland men's study of risks in a low-prevalence area. Cleve Clin J Med (1992) 1.41
Mapping of T cell epitopes of the 30-kDa alpha antigen of Mycobacterium bovis strain bacillus Calmette-Guérin in purified protein derivative (PPD)-positive individuals. J Immunol (1995) 1.40
Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun (1996) 1.39
Homicide and suicide in a metropolitan county. I. Long-term trends. JAMA (1973) 1.39
Delayed tuberculin reactivity in persons of Indochinese origin: implications for preventive therapy. Ann Intern Med (1996) 1.39
Accidental firearm fatalities in a metropolitan county (1958-1973). Am J Epidemiol (1974) 1.38
Homicide in New York City. Cocaine use and firearms. JAMA (1994) 1.36
Suppression of lymphocyte responses by tuberculous plasma and mycobacterial arabinogalactan. Monocyte dependence and indomethacin reversibility. J Clin Invest (1981) 1.36
Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis. Am Rev Respir Dis (1986) 1.35
Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment. J Infect Dis (1998) 1.33
Increased replication of HIV-1 at sites of Mycobacterium tuberculosis infection: potential mechanisms of viral activation. J Acquir Immune Defic Syndr (2001) 1.29
Risk factors for relapse in human immunodeficiency virus type 1 infected adults with pulmonary tuberculosis. Int J Tuberc Lung Dis (1997) 1.29
Clinical management of keratoconus. A multicenter analysis. Ophthalmology (1990) 1.29
Poverty and fatal accidental drug overdoses of cocaine and opiates in New York City: an ecological study. Am J Drug Alcohol Abuse (1997) 1.28
Pleural fluid and peripheral blood lymphocyte function in tuberculosis. Ann Intern Med (1978) 1.28
Non-specific suppression of antigen-induced lymphocyte blastogenesis in Onchocerca volvulus infection in man. Clin Exp Immunol (1983) 1.28
Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J Infect Dis (1994) 1.27
Safety and bactericidal activity of rifalazil in patients with pulmonary tuberculosis. Antimicrob Agents Chemother (2001) 1.27
Talking to the family after an autopsy. Arch Pathol Lab Med (1984) 1.27
Haemophilus influenzae meningitis: the spectrum of disease in adults. Medicine (Baltimore) (1982) 1.27
The epidemiology of murder-suicide. JAMA (1992) 1.27
Impact of mouth rinsing before sputum collection on culture contamination. Afr Health Sci (2009) 1.26
Violent death in a metropolitan county: II. Changing patterns in suicides (1959-1974). Am J Public Health (1979) 1.26
Role of the mononuclear phagocyte as an antigen-presenting cell for human gamma delta T cells activated by live Mycobacterium tuberculosis. Infect Immun (1992) 1.26
Chronic meningitis. Medicine (Baltimore) (1976) 1.25
Antigen handling by guinea pig macrophages: further evidence for the sequestration of antigen relevant for activation of primed T lymphocytes. J Immunol (1977) 1.25
Expression of functional interleukin 2 receptors by peripheral blood monocytes from patients with active pulmonary tuberculosis. J Clin Invest (1990) 1.24